Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease; First clinical study of a rationally-defined bacterial consortium for an immune-mediated disease; Miles

Media coverage

• Title	Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease; First clinical study of a rationally-defined bacterial consortium for an immune-mediated disease; Miles
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	27/11/18
  Persons	Jeremiah Faith